Potassium supplementation via the dialysate in continuous ambulatory peritoneal dialysis.
A small percentage of patients treated with continuous ambulatory peritoneal dialysis (CAPD) may become hypokalemic. Since both the intravenous and oral routes for potassium repletion have disadvantages, we studied the feasibility, effectiveness, and safety of acute potassium loading via the dialysate in patients on CAPD. Five patients were studied during an exchange containing 20 mEq/L of potassium. This was well tolerated and led to a gradual increase in the plasma potassium concentration (.44 +/- .11 mEq/L) as about three-fourths of the intraperitoneal load was absorbed, most of it by two hours. The greatest increase in the plasma potassium concentration was .63 mEq/L. A separate patient developed intense abdominal pain during an exchange containing 40 mEq/L of potassium. We conclude that the dialysate is a safe and effective route for acute potassium repletion during CAPD when the dialysate potassium concentration does not exceed 20 mEq/L.
D000005:Abdomen; D000328:Adult; D000368:Aged; D005240:Feasibility Studies; D005260:Female; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism; D006801:Humans; D007008:Hypokalemia / Q000097:blood / Q000150:complications / Q000188:drug therapy; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D009120:Muscle Cramp / Q000139:chemically induced; D010146:Pain / Q000139:chemically induced; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011188:Potassium / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000378:metabolism; D012996:Solutions
D007328:Insulin; D012996:Solutions; D005947:Glucose; D011188:Potassium